Does Nurturance help shorten sales cycles for insurtech companies in the UK

Cormac Repman
2 days ago
4 min read

The Insurtech Sales Cycle Problem

Most insurtech founders assume a 12 to 18-month sales cycle is just part of the game. It's not. When you're selling into traditional insurance operations, procurement takes time. But that doesn't mean you sit passively waiting for inbound leads to find you.

We've watched hundreds of B2B tech companies in the fintech and insurtech space spend that entire period guessing whether they have product-market fit. By the time a prospect finally decides, they've either solved the problem another way or moved on to a competitor.

The real issue isn't the sales cycle itself. It's the gap between first contact and second contact.

Why Insurtech Sales Cycles Stall

Most insurtech deals stall for one reason: lack of consistent, qualified contact.

Your inbound funnel gets maybe 30-40 signups a month if you're doing content marketing well. Your sales team chases every one. Meanwhile, 300 other prospects who would genuinely benefit from your platform never hear from you because you don't have their details and you don't have time to find them.

When I run cold calling outreach for insurtech clients, I'm not trying to close anyone on the first call. I'm doing one thing: getting them to take the second meeting.

That second meeting is where the sales cycle actually starts.

How Nurturance Shortens Your Insurtech Sales Cycle

We use real human callers working from a managed team model. We're not trying to automate away the relationship building. We're systematizing the hard part: finding the right person at a UK insurtech or traditional insurer, getting them on a call, and handing them qualified to your sales team.

Here's what changes when you bring structured outbound in house:

Connect rates from cold outreach typically sit at 12 to 18% when you're working with a real calling team. That means if we work 500 decision makers at insurance operations in the UK, you're meeting with 60 to 90 of them in week one.

More importantly: those 60 people know why you called. They didn't accidentally sign up for your webinar. They took the call because someone described exactly how your platform solves their data reconciliation problem or their underwriting delay.

The Math: Pipeline Velocity vs. Sales Cycle Length

Let's say your average insurtech deal is worth 35k per year. Your sales team closes 1 in 5 qualified meetings. That's a 20% close rate. Most insurtech companies get 15 to 20 qualified meetings per month through inbound.

So your monthly pipeline value sits at roughly 105k to 140k. That feels solid until you realize it takes 14 months to close it all.

Now run the math with outbound in place. Same conversion rate. But now you're getting 60 qualified meetings per week instead of 15 per month. In the same 14-month window, your total pipeline is now closer to 1.2 million.

The sales cycle doesn't shorten. Your execution velocity does. You close more deals in the same timeframe because you have more qualified people moving through the pipeline simultaneously.

Insurtech Buyers Want to Be Found

I've listened to thousands of calls with insurance operations directors and chief underwriters in the UK. Here's what I've learned: they don't hate cold calls. They hate irrelevant ones.

When a caller knows their company uses legacy policy admin systems and positions a conversation around migration costs versus your platform's ROI, the call happens. When someone leads with "we're a sales tech company," it's a quick no.

Real outbound means targeting by role, by company type, by their actual business problem. Insurance brokers in London face different pressures than insurtech startup buyers in Manchester. Your outreach has to reflect that.

We layer in firmographic data, recent funding events, and regulatory changes to make sure every conversation starts from a place of earned credibility.

How Your Sales Team Actually Benefits

Short-cycle deals need preparation. When you hand someone a meeting, your sales team already knows:

Why that person's company needs you (not why we think they should want you)

What their current process looks like and where the pain point sits

Who else is involved in the buying decision

What timeline they're actually working to

That context cuts the discovery phase in half. Instead of spending two meetings figuring out if there's a fit, you spend one.

Getting Started With Outbound

If you've never run cold outreach before, here's the actual workflow:

Define your target universe - UK insurance companies by type (brokers, MGAs, traditional carriers), then by size and process stage. We typically start with 200 to 300 of the highest-priority targets.

Build your messaging - Not a pitch. A diagnostic question. "We've seen underwriting teams cut turnaround time on complex policies by 40% when they..." That's an opening. "Do you have time for a quick call?" is where you close it.

Hire or outsource the calling - You can build an internal team, or use outsourced callers. Either way, you need someone whose only job for the next 60 days is making these calls. Not sales development. Not marketing. Just calling.

Track what actually converts - After 100 calls, you'll know which messaging lands with brokers, which lands with MGAs, and which lands with compliance teams. Stop using the stuff that doesn't work.

The insurtech sales cycle isn't slow because the market doesn't want what you're selling. It's slow because only a fraction of the people who need you actually know you exist.

Nurturance runs outbound campaigns for B2B companies like yours. We manage real teams of callers, handle the dialing, the objection handling, and the meeting booking. You get qualified meetings with UK insurance operators who are genuinely interested in hearing your story.

If you're ready to shorten your sales cycle, let's talk about what a 60-day sprint looks like for your company. Book a time with us here and we'll map out how many qualified conversations we can generate.